There Is Another Way
Building a health-sciences company powered by Humans + AI, not just humans
At FMG Health Sciences — the company behind Mitozz — we made a deliberate choice: design our organization from the ground up for the future that is already here. Not more layers, more offices, or more headcount. Instead, a lean, flat, globally distributed model powered by humans + AI as true partners.
The Modern CEO Tension
As a CEO in health sciences today, you feel the pull in both directions every single day.
You need to scale rapidly, whether it’s growing a nutraceutical business today or preparing a pharmaceutical pipeline for global reach tomorrow, while staying lean, focused, and fully in control of quality, compliance, and culture.
The default playbook most companies still follow is understandable: add layers, add offices, add headcount. It feels like the safe, proven way to handle complexity. Yet in practice it often creates the very friction it was meant to solve:
- slower decisions,
- diluted accountability,
- fragmented knowledge, and
- an organization that starts to feel heavy just when agility matters most.
We felt that tension acutely as FMG moved from startup sprint into disciplined growth mode in a short period of time. The usual path risked turning us into something we didn’t want to become. So we paused, stepped back, and asked a different question: what would an organization look like if it were deliberately designed for the humans + AI era instead of the industrial-era model we inherited?
Our Core Philosophy
FMG Health Sciences is being built as a lean, flat, globally distributed organization powered by humans + AI, not just humans.
This is not about bolting AI onto an existing structure or using it simply as a productivity tool. It is a fundamental redesign of how the entire company operates, so that human judgment and AI capability amplify each other at every level, creating speed, resilience, clarity, and focus that traditional organizations simply cannot match.
Three guiding principles shape everything we do:
- Lean & flat by design — keeping the structure intentionally minimal so ownership stays high and decisions stay fast.
- Globally distributed with extreme focus — operating across continents with only a handful of physical offices while maintaining tight coordination and data sovereignty.
- Human accountability paired with AI as true strategic partner — AI acts as an always-on Chief of Staff and execution layer, but humans remain fully accountable for every final decision, especially on regulatory, financial, and clinical matters.
This philosophy powers everything at FMG, including the mitochondrial-support science and products we bring to market. It’s how we intend to scale thoughtfully, today and for the next decade.
Learn more about our science and Mitozz.
Early Signals & What It Feels Like
We launched FMG Health Sciences in 1月 2025. In the 15 months since, we have moved from startup sprint into full growth mode, now selling across multiple continents, launching new nutraceutical products, and actively preparing multiple pharmaceutical candidates for global rollout.
All of this while navigating the real, messy challenges every fast-scaling health-sciences company faces:
- complex global operations,
- multi-jurisdiction regulatory and compliance demands,
- supply-chain coordination, and
- the constant pressure of bringing new science to market at speed.
It’s still early, and the design itself is very much a work in progress. We are continuously refining it as we go. The signals we are seeing internally are already unmistakable and encouraging.
Decisions that once took days now move in hours, not because anyone is working harder, but because the right information and the right questions surface faster. Ownership feels sharper because every leader (and every AI partner) has clear, dual-hat responsibilities and exception-based reporting. The entire organization simply feels lighter and more resilient by design rather than from heroic effort.
This is what thoughtful, future-ready design feels like in practice: calm confidence instead of constant firefighting, strategic depth instead of reactive busyness, and a genuine sense that humans and AI are working together as true partners.
As we continue progressing in this journey, we invite you to come join us, follow the weekly series, share your own experiences, and let’s learn together what scaling a health-sciences company in the humans + AI era really looks like.
Join the Conversation
We are quietly proving there is another way, and we would value your perspective.
Join a small, thoughtful group of leaders receiving occasional updates from this series and early lessons from living the Humans + AI model.
No spam, just principled signals and real-world reflections.
Follow the weekly LinkedIn series
We read every comment and every message. The conversation is open.